TY - JOUR
T1 - Burden of lower respiratory infections in the Eastern Mediterranean Region between 1990 and 2015
T2 - findings from the Global Burden of Disease 2015 study
AU - GBD 2015 Eastern Mediterranean Region Lower Respiratory Infections Collaborators
AU - Moradi-Lakeh, Maziar
AU - El Bcheraoui, Charbel
AU - Charara, Raghid
AU - Khalil, Ibrahim
AU - Afshin, Ashkan
AU - Kassebaum, Nicholas J.
AU - Collison, Michael
AU - Daoud, Farah
AU - Chew, Adrienne
AU - Krohn, Kristopher J.
AU - Colombara, Danny
AU - Ehrenkranz, Rebecca
AU - Foreman, Kyle J.
AU - Frostad, Joseph
AU - Godwin, William W.
AU - Kutz, Michael
AU - Rao, Puja C.
AU - Reiner, Robert
AU - Troeger, Christopher
AU - Wang, Haidong
AU - Abajobir, Amanuel Alemu
AU - Abbas, Kaja M.
AU - Abera, Semaw Ferede
AU - Abu-Raddad, Laith J.
AU - Adane, Kelemework
AU - Kiadaliri, Aliasghar Ahmad
AU - Ahmadi, Alireza
AU - Ahmed, Muktar Beshir
AU - Al-Eyadhy, Ayman
AU - Alam, Khurshid
AU - Alam, Noore
AU - Alasfoor, Deena
AU - Alizadeh-Navaei, Reza
AU - Al-Maskari, Fatma
AU - Al-Raddadi, Rajaa
AU - Alsharif, Ubai
AU - Altirkawi, Khalid A.
AU - Anber, Nahla
AU - Ansari, Hossein
AU - Antonio, Carl Abelardo T.
AU - Anwari, Palwasha
AU - Asayesh, Hamid
AU - Asgedom, Solomon Weldegebreal
AU - Atey, Tesfay Mehari
AU - Arthur Avokpaho, Euripide Frinel G.
AU - Bacha, Umar
AU - Barac, Aleksandra
AU - Bazargan-Hejazi, Shahrzad
AU - Bedi, Neeraj
AU - Bhutta, Zulfiqar A.
N1 - Funding Information:
Dr. Carl Abelardo T. Antonio reports Grants and personal fees from Johnson and Johnson (Philippines), Inc. outside the submitted work. Dr. Jasvinder Singh serves as the principal investigator for an investigator-initiated study funded by Horizon Pharmaceuticals through a grant to DINORA, Inc., a 501 (c)(3) entity. Dr. Singh is a member of the executive of OMERACT, an organization that develops outcome measures in rheumatology and receives arms-length funding from 36 companies; a member of the American College of Rheumatology’s (ACR) Annual Meeting Planning Committee (AMPC); Chair of the ACR Meet-the-Professor, Workshop and Study Group Subcommittee; and a member of the Veterans Affairs Rheumatology Field Advisory Committee. Other authors have no conflict of interest.
Funding Information:
The authors would like to acknowledge Adrienne Chew at the Institute for Health Metrics and Evaluation, Seattle, WA, for editing this paper. This research was funded by the Bill and Melinda Gates Foundation.
Publisher Copyright:
© 2017, The Author(s).
PY - 2018/5/1
Y1 - 2018/5/1
N2 - Objectives: We used data from the Global Burden of Disease 2015 study (GBD) to calculate the burden of lower respiratory infections (LRIs) in the 22 countries of the Eastern Mediterranean Region (EMR) from 1990 to 2015. Methods: We conducted a systematic analysis of mortality and morbidity data for LRI and its specific etiologic factors, including pneumococcus, Haemophilus influenzae type b, Respiratory syncytial virus, and influenza virus. We used modeling methods to estimate incidence, deaths, and disability-adjusted life-years (DALYs). We calculated burden attributable to known risk factors for LRI. Results: In 2015, LRIs were the fourth-leading cause of DALYs, causing 11,098,243 (95% UI 9,857,095–12,396,566) DALYs and 191,114 (95% UI 170,934–210,705) deaths. The LRI DALY rates were higher than global estimates in 2015. The highest and lowest age-standardized rates of DALYs were observed in Somalia and Lebanon, respectively. Undernutrition in childhood and ambient particulate matter air pollution in the elderly were the main risk factors. Conclusions: Our findings call for public health strategies to reduce the level of risk factors in each age group, especially vulnerable child and elderly populations.
AB - Objectives: We used data from the Global Burden of Disease 2015 study (GBD) to calculate the burden of lower respiratory infections (LRIs) in the 22 countries of the Eastern Mediterranean Region (EMR) from 1990 to 2015. Methods: We conducted a systematic analysis of mortality and morbidity data for LRI and its specific etiologic factors, including pneumococcus, Haemophilus influenzae type b, Respiratory syncytial virus, and influenza virus. We used modeling methods to estimate incidence, deaths, and disability-adjusted life-years (DALYs). We calculated burden attributable to known risk factors for LRI. Results: In 2015, LRIs were the fourth-leading cause of DALYs, causing 11,098,243 (95% UI 9,857,095–12,396,566) DALYs and 191,114 (95% UI 170,934–210,705) deaths. The LRI DALY rates were higher than global estimates in 2015. The highest and lowest age-standardized rates of DALYs were observed in Somalia and Lebanon, respectively. Undernutrition in childhood and ambient particulate matter air pollution in the elderly were the main risk factors. Conclusions: Our findings call for public health strategies to reduce the level of risk factors in each age group, especially vulnerable child and elderly populations.
KW - DALY
KW - Eastern Mediterranean Region
KW - Incidence
KW - Lower respiratory infection
KW - Mortality
UR - http://www.scopus.com/inward/record.url?scp=85026828839&partnerID=8YFLogxK
U2 - 10.1007/s00038-017-1007-0
DO - 10.1007/s00038-017-1007-0
M3 - Article
C2 - 28776246
AN - SCOPUS:85026828839
SN - 1661-8556
VL - 63
SP - 97
EP - 108
JO - International Journal of Public Health
JF - International Journal of Public Health
ER -